EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS

• Main Authors: S. Y. Martsevich (Author), J. V. Lukina (Author), V. V. Yakusevich (Author), D. A. Anichkov (Author), A. D. Deev (Author), O. V. Lerman (Author), S. N. Tolpygina (Author), N. A. Dmitrieva (Author), A. A. Serazhim (Author), M. A. Maksimova (Author), V. P. Voronina (Author), E. V. Shilova (Author), G. F. Andreeva (Author), A. V. Zaharova (Author), I. V. Novikov (Author), А. А. Platonova (Author), Т. А. Kazakovtseva (Author), T. V. Babkova (Author), L. P. Volhonskaya (Author)
• Format: Book
• Published: Столичная издательская компания, 2016-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. To study adjuvant effect of betahistine dihydrochloride to ACE inhibitors in patients with chronic heart failure (CHF) class II-III suffering from giddiness.Material and methods. 61 patients with CHF class II-III, ejection fraction ≤45% (Simpson) suffering from giddiness were involved into rand...